PKU Exchange
Home
PKU Drug Set for Successful Launch
Kuvan, BioMarin's new PKU treatment, looks set to gain approval in Q4 2007, with the review date set for 25th November this year. Health insurance companies in the USA have already admitted that they would have to meet the cost of Kuvan for PKU patients, as it is currently the only available treatment.
Kuvan, BioMarin's new PKU treatment, looks set to gain approval in Q4 2007, with the review date set for 25th November this year. Health insurance companies in the USA have already admitted that they would have to meet the cost of Kuvan for PKU patients, as it is currently the only available treatment.
Latest Headlines
Details about the second annual Pittsburgh PKU Walk-A-Thon on Saturday May 19 2007.
Vicki Racette has organised a PKU Cruise of the Eastern Caribbean Cruise with Carnival Cruiselines.
Unfortunately, we've had a problem with our hosting company and as a result approximately 5 days of posts have been lost from the message boards.
BioMarin Pharmaceutical announced today that recent studies int Phenylase suggest that they have "successfully addressed key technical challenges associated with its development for the treatment of phenylketonuria."